MarketInOut Stock Screener Log In | Sign Up

Pacific Biosciences of California Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026
Pacific Biosciences of California Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization930.94 mln
Float284 mln
Earnings Date11/04/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-6.06
Highly reliable

1-Year Forecast

2.54
Fairly priced

Relative Strength

99 / 100
Top performer

Pre-Tax Margin

-82%
Severely loss-making

ROE

-911
Deeply negative

Business Description

Pacific Biosciences of California, founded in 2000 and based in Menlo Park, develops and sells advanced DNA sequencing systems, instruments, and related reagent kits used to analyze complex genetic information. The company's products serve a wide range of customers, including universities, hospitals, pharmaceutical firms, and agricultural businesses across North America, Europe, Asia, and beyond. Its sequencing technology supports both long- and short-read analysis, giving researchers powerful tools to study genetic material at a high level of detail.

Key Fundamentals

EPS-0.43
ROE-911
RPS0.52
ROIC-34.82
ROA-16.64
Interest Cover-42.23
EBITDA, mln-106
EV / EBITDA-11.60
EV / EBIT-9.99
Revenue, mln159
EV / Revenue7.73

Quote Details

Last 2.61
Change -0.29 (-10%)
Open 2.75
Volume 13,723,090
Turnover 35,817,264
Average Volume 16,462,086

Financial Ratios

Pre-Tax Profit Margin-82
Current Ratio4.92
Price / Sales4.68

Financial Strength

Altman Z-Score-4.43
Piotroski F-Score 4 / 9
Beneish M-Score-6.06
1-Year Target Price2.54
Short Ratio2.56
Short % of Float17.36

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 23.7% 98 / 100   
1 Month 3.98% 82 / 100   
2 Months 91.91% 99 / 100   
6 Months 63.12% 97 / 100   
1 Year 29.85% 85 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog